Home | Welcome to Contract Pharma   
Last Updated Sunday, October 19 2014
Print

Synerlab Acquires Lyofal



Published November 15, 2012
Related Searches: CMO Dosage formulation Outsourcing
Synerlab, a French CMO, has acquired Lyofal, gaining access to the growing market of lyophilized dosage forms, and expanding its existing range of outsourcing services. Financial terms of the acquisition were not disclosed.
 
Lyofal’s core business is outsourcing lyophilization services, providing services from determining lyophilization parameters, formulation assistance, and improvement of existing cycles within R&D, to production of pilot and industrial scale for bulk products (APIs, plant or animal extracts), as well as vials (diagnostic use) or molded forms (haemostatic patches or medical devices).
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On